Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New crystal form of prasugrel and preparation method thereof

A technology of prasugrel and crystal form, which is applied in the field of medicine and chemical industry, can solve the problems that prasugrel free base is not suitable for drug synthesis, and achieve the effects of shortening the production route, simple preparation process and equivalent dissolution rate

Active Publication Date: 2017-06-09
CSPC ZHONGQI PHARM TECH (SHIJIAZHUANG) CO LTD
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] In order to solve the technical problem that the existing prasugrel free base is not suitable for synthetic medicine, the inventors of the present invention provided three new crystal forms of prasugrel with good stability, high solubility and high dissolution rate and their preparation after extensive research. method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New crystal form of prasugrel and preparation method thereof
  • New crystal form of prasugrel and preparation method thereof
  • New crystal form of prasugrel and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] Example 1 Preparation of prasugrel M crystal form

[0056] Add 2 grams of prasugrel crude product into 6ml 1,4-dioxane, heat to 30 degrees to dissolve, slowly cool down to room temperature under stirring condition, a white solid precipitates, continue to stir for 2 hours, filter to obtain white crystals, Vacuum dried to obtain 1.71 g of the product, with a yield of 85.5%.

Embodiment 2

[0057] Example 2 Preparation of prasugrel M crystal form

[0058] Add 2 grams of prasugrel crude product into 6ml tetrahydrofuran, heat to 30 degrees to dissolve, slowly cool down to room temperature under stirring condition, a white solid precipitates out, continue to stir for 0.5 hours, filter to obtain white crystals, and vacuum dry to obtain the product 1.58 grams, yield 79.0%.

Embodiment 3

[0059] Example 3 Preparation of prasugrel N crystal form

[0060] Add 2 grams of prasugrel crude product to 10ml of a mixed solvent of methyl ethyl ketone:petroleum ether=1:2, heat to 80 degrees to dissolve, let it stand and slowly cool down to room temperature, a white solid precipitates, grow crystals for 2 hours, filter to obtain White crystals were vacuum-dried to obtain 1.66 g of the product, with a yield of 83.1%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
strengthaaaaaaaaaa
strengthaaaaaaaaaa
Login to View More

Abstract

The invention discloses a new crystal form of prasugrel, and also discloses a preparation method thereof. The invention solves the problem that prasugrel is unfavorable for making medicines. The invention has the beneficial effects of providing multiple new prasugrel crystal forms, which have the advantages of good stability, good dissolution rate after being prepared as a medicine, and the like.

Description

technical field [0001] The invention belongs to the field of medicine and chemical industry, and in particular relates to a new crystal form of an antithrombotic drug prasugrel and a preparation method thereof. Background technique [0002] The chemical name of prasugrel is 2-acetoxy-5-(a-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c ] pyridine, the structural formula is as shown in formula I. Prasugrel is an oral antiplatelet drug jointly developed by Eli Lilly and its partner Daiichi Pharmaceutical Sankyo, [0003] [0004] Formula I. [0005] Prasugrel, an adenosine diphosphate (ADP) receptor antagonist, is a prodrug that is effectively converted in vivo to its active metabolite R-138727. R-138727 reduces the dependence on cytochrome P-450 enzymes, and rapidly, specifically, and irreversibly binds to the purine base receptor of platelet P2Y12, inhibits the activity and aggregation of platelets regulated by ADP, and thus plays an anti-platelet ef...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D495/04
CPCC07D495/04
Inventor 张雅然李蒙道硕刘磊娜何晓燕李少华金晓利
Owner CSPC ZHONGQI PHARM TECH (SHIJIAZHUANG) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com